PRGO - Perrigo Quarterly EPS earnings growth
Perrigo Company plc management is currently restructuring to develop consumer healthcare and reduce debt. The relative quarterly change in EPS clearly demonstrates how the -464.90 metric reflects current dynamics. Business revenues are based on mass supplies of over-the-counter products to retail chains. Stability is ensured by a strong staff of technologists and the implementation of automation at plants.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_PRGO_-_Perrigo-Company-plc_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "perrigo.com (PRGO): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/14/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns for Perrigo Company plc
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Capital Perrigo Company plc|PRGO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Perrigo Company plc|PRGO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Perrigo Company|PRGO - Company Long-Term Loans and Borrowings|Company Short-Term Debts Perrigo|Quick Ratio perrigo.com
- earnings and market multiples details:
PRGO - Annual Net Income|Expected Profit Perrigo Company plc|PRGO - Market Cap to Earnings|Projected Price to Earnings Perrigo Company|PRGO - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Perrigo Company|PRGO - Operating profit before deduction of amortization|Earnings per share for the last twelve months Perrigo|PRGO - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months perrigo.com|PRGO - Net earnings per share growth this year|Net earnings per share growth forecast for next year Perrigo Company plc
- sales revenue and business income indicators:
Summary company analytics:Perrigo Company plc
Finding a balance between asset value and business quality requires an analysis of real returns. This indicator measures the dynamics of net profit per share, filtering out market noise and emotional speculation. For Perrigo Company plc (PRGO), this calculation reflects the efficiency of diversification across the over-the-counter (OTC) and hygiene segments. Stability of supplies to retail chains in the US and Europe directly impacts the bottom line. The trajectory of quarterly EPS growth allows for an objective assessment of the company's resilience.
Who Perrigo Company plc competes with
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Alvotech SA ALVO|LQDA (Liquidia Corp) - Year-over-year net earnings per share trend for the last twelve months|Galapagos Genomics - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ANI Pharmaceuticals Corp|MannKind Corporation (MNKD) - Year-over-year earnings per share growth for the last twelve months|amphastar.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Pacira BioSciences, Inc.|SPRY: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TBPH|Year-over-year net earnings per share change for the last twelve months Aquestive Corp|Quarterly EPS earnings growth SCPH (scPharmaceuticals)|Net earnings per share growth for the trailing year Tectonic Therapeutic Inc.|TNXP - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months China SXT Pharmaceuticals|EPRX (eupraxiapharma.com) - Year-over-year net earnings per share growth for the last 12 months|BioHarvest Sciences Inc - Year-over-year earnings per one share growth for the last 12 months|EXOZ (eXoZymes Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Oramed Pharma (ORMP)|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months ABVC BioPharma Inc ABVC|CPIX - Year-over-year net earnings per share growth for the last 12 months|QNTM - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months FGEN|TELO: Quarterly EPS earnings growth|Rani Therapeutics Holdings, Inc. (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Year-over-year earnings per share growth for the last 12 months RLYB (Rallybio Corp.)|Year-over-year net earnings per share growth for the last 12 months LEXX (Lexaria Bioscience)|PULM - Earnings per share growth in annualized terms for the last twelve months|Pheton Holdings - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months APM|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months IBO|tnfpharma.com (TNFA) - Year-over-year earnings per share growth for the last twelve months|YCBD (cbdMD) - Year-over-year earnings per share growth for the last twelve months|PRFX (PainReform) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Auris Medical (CYTO)|Year-over-year earnings per share growth for the last twelve months Lipella (LIPO)|OPTN: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals PIRS|Year-over-year earnings per one share growth for the last 12 months PROC|Petros Pharmaceuticals, Inc. - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Qilian International Holding Group (QLI)|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months TFF Pharmaceuticals, Inc (TFFP)
